APYXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Apyx Medical Corp

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$2.42−0.13 (-5.10%)

Close on Oct 19, 2026

Market cap: $106.12M
P/E (TTM): –
Dividend yield: –

Apyx Medical Corp income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Revenue	53	48	52	45	49	28	28	17	10	8.82	30	28	24	28	25	24	27
Cost of Revenue	20	19	19	15	15	10	9.14	5.78	3.28	3.70	17	19	14	16	15	14	15
Gross Profit	33	29	34	29	34	18	19	11	6.96	5.12	13	8.99	9.20	11	11	9.99	12
Research & Development	3.37	5.08	5.44	4.54	4.32	3.92	3.73	2.55	1.94	1.03	2.16	1.42	1.26	1.33	1.20	1.85	2.08
Selling, General & Admin	16	19	22	20	19	12	14	9.41	8.69	6.19	8.42	6.69	5.78	4.34	4.35	4.89	4.66
Advertising Expenses	1.60	1.30	1.80	2.30	1.30	0.80	1.50	0.80	1.10	0.70	0.50	0.50	0.31	0.28	0.31	0.28	–
Operating Expenses	39	48	54	53	48	38	40	25	21	17	20	15	–	–	–	–	–
Operating Income	-6.45	-19	-17	-24	-14	-20	-21	-14	-14	-11	-6.99	-5.85	-3.67	1.05	-0.02	-2.75	0.72
Interest Expense	5.59	5.91	2.48	0.02	0.01	0.05	0.01	0.10	0.14	0.16	–	–	–	–	–	–	–
Interest & Investment Income	1.11	1.61	0.92	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Other Non-Operating Income	-4.39	-4.46	-4.02	0.65	-0.37	0.67	1.03	-0.42	0.05	-0.09	1.64	-7.44	-2.29	-0.21	0.05	0.29	-0.05
Asset Impairment Charges	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	1.29	0
Gain (Loss) on Investments	–	–	–	–	–	0	0.16	0.25	0	–	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	-0.02	-0.01	2.53	-0.08	-0.05	-0.01	-0.09	0	-0.01	-0.02	-0.02	-0.01	-0.02	0.04	–	–	–
Legal Settlements	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.75	–	–
Pretax Income	-11	-23	-21	-23	-15	-19	-20	-15	-14	-11	-5.35	-13	-5.95	0.83	0.03	-2.46	0.66
Income Tax Expense	0.27	0.25	-2.43	0.37	0.38	-7.50	-0.13	-3.91	-0.16	0.06	0.03	4.00	-1.61	0.22	0.08	-0.93	0.07
Income from Continuing Operations	–	–	–	–	–	–	-20	-11	-14	-12	–	–	–	–	–	–	–
Income from Discontinued Operations	–	–	–	–	–	–	0	5.10	8.62	7.60	–	–	–	–	–	–	–
Net Income incl. Noncontrolling Interests	-11	-24	-19	-23	-15	-12	-20	–	–	–	–	–	-4.34	0.62	0.11	–	–
Minority Interest in Earnings	0.11	-0.10	-0.14	-0.09	-0.03	-0.01	0	–	–	–	–	–	–	–	–	–	–
Net Income	-11	-23	-19	-23	-15	-12	-20	63	-5.06	-12	-5.37	-17	-4.34	0.62	0.11	-1.54	0.60
Net Income to Common	-11	-23	-19	-23	–	–	-20	63	-5.06	-3.95	8.36	-18	-6.99	0.62	–	–	–
EPS (Basic)(per share)	-0.27	-0.66	-0.54	-0.67	-0.44	-0.35	-0.58	1.89	-0.16	-0.14	0.34	-1.03	-0.40	0.04	0.01	-0.09	0.04
EPS (Diluted)(per share)	–	–	-0.54	-0.67	-0.44	-0.35	-0.58	1.83	-0.17	-0.15	0.24	-1.03	-0.40	0.03	0.01	-0.09	0.03
Shares Outstanding (Basic, Weighted)(shares)	41	36	35	35	34	34	34	33	31	27	24	18	18	0.02	0.02	17	17
Shares Outstanding (Diluted, Weighted)(shares)	41	36	35	35	34	34	34	34	31	27	28	18	18	0.02	0.02	17	17
EBITDA	-5.79	-18	-17	-23	-14	-19	-20	-14	-13	-11	-6.17	-4.97	-2.84	1.79	0.74	-2.02	1.49
Net Interest Income	–	–	–	–	–	–	–	–	-0.14	-0.16	-0.16	-0.15	-0.24	-0.23	-0.24	-0.22	-0.05

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 63.5%
Operating margin: -6.1%
Net margin: -14.8%
Return on equity, FY2025: -78.0%

Financial strength

Current ratio: 5.68
Debt to equity: 3.31
Debt to assets: 57.8%
Cash to current liabilities: 295.2%

Valuation

P/E ratio: –
Price to sales: 1.82
Price to book: 9.95
Dividend yield: –